Acta psychiatrica Scandinavica
-
Acta Psychiatr Scand · Apr 2011
ReviewSelective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.
To assess the methodological value of studies that signaled one or more selective serotonin reuptake inhibitors (SSRIs) as teratogenic agents. ⋯ In light of such considerations, the hypothesized teratogenicity of SSRIs remains undemonstrated. Hence, further, well-designed research is needed to differentiate definitively the detrimental impact of depression on pregnancy outcomes from potential iatrogenic events.